跳至主要内容
临床试验/NCT01715649
NCT01715649已完成不适用

Evaluation of a Telehealth Intervention Combining Structured Self-Monitoring of Blood Glucose and Nurse Care Coordination Among People With Type 2 Diabetes Noninsulin-Treated

Sutter Health2 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2012年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Sutter Health
入组人数
90
试验地点
2
主要终点
Hemoglobin A1c

研究概览

简要总结

Telehealth remote patient monitoring is a means of using communications technology - such as telephones, computers, and the Internet - to connect patients remotely with their healthcare team from their homes. The investigators hope to learn more about improving healthy behaviors and blood glucose among persons with diabetes using telehealth remote patient monitoring technology to connect directly with nurse care coordinators.

The purpose of this study is to evaluate a process for improving blood glucose and healthy behaviors among people with type 2 diabetes using telehealth remote patient monitoring technology with nurse care coordinators. Some of the people in this study will work with a nurse care coordinator who will review your blood glucose weekly and call you at home every month for 3 months, while some of the people in this study will simply receive their normal care. At the end of the study, every participant will be asked questions about how they feel about their health care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Enrolled in diabetes disease management program
  • ages 30-70
  • HbA1c between 7.5% and 10.9% in the previous six months
  • an Internet or 3G connection and email address;
  • a working phone line (land line or cellular); and
  • ability to read and understand the English language.

排除标准

  • taking insulin;
  • inability to independently engage in self-management behaviors (diagnosis of dementia, severe depression, schizophrenia, or cognitive impairment);
  • severe complications, which would preclude achieving an HbA1c goal of 7% including diagnosis of the following:
  • severe stroke;
  • heart failure;
  • end-stage renal disease;
  • kidney dialysis; and
  • legally blind.

结局指标

主要结局

Hemoglobin A1c

时间窗: Change from baseline to 6 months

Lab test

次要结局

  • Empowerment(Change from baseline to 3 months)
  • Behavior Change(Change from baseline to 3 months)
  • Knowledge(Change from baseline to 3 months)

研究者

发起方
Sutter Health
申办方类型
Other
责任方
Principal Investigator
主要研究者

Deborah Greenwood

Diabetes Clinical Nurse Specialist

Sutter Health

研究点 (2)

Loading locations...

相似试验